title: Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study.
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Batteux
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France.
authors.forename: Agathe
authors.initials: A
authors.lastname: Devauchelle
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France.
authors.forename: Pauline Lasselin
authors.initials: PL
authors.lastname: Boyard
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France.
authors.forename: Alice
authors.initials: A
authors.lastname: Sejourné
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France.
authors.forename: Patrice
authors.initials: P
authors.lastname: Fardellone
authors.affiliation: Service de rhumatologie, CHU d'Amiens, place Victore-Pauchet, 80054 Amiens cedex 1, France; EA4666, Université de Picardie-Jules-Verne, chemin du Thil, 80000 Amiens, France. Electronic address: goeb.vincent@chu-amiens.fr.
authors.forename: Vincent
authors.initials: V
authors.lastname: Goëb
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D055118:Medication Adherence; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D012189:Retrospective Studies; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept; D008727:Methotrexate
keywords: Ankylosing spondylitis; Drug retention rate; Psoriatic arthritis; Rheumatoid arthritis; TNFα antagonist